 Outcome measures: 1 Gene changes induced by statin treatment by dosage and over time; 2 Accuracy of vascular gene panel for defining gene expression changes induced by statin treatment; and 3 Correlations of gene expression changes with conventional vascular risk factors, changes in lipid and inflammatory markers and determination of best vascular risk prediction paradigm. 